Understandably, the news event holding the strongest gravitational pull on the media right now is the hemorrhage of oil in the Gulf. From the day of the rig’s explosion and toppling on the ocean’s surface, through every failed attempt to cap the leak one mile down in the weeks that have followed, our heavy hearts force us all to question our faith in technology.
But while the struggle continues, somewhere in the long, murky shadow of BP are other successful disaster-relief technologies worthy of restoring some of that faith.
Tonight John Sabia will cast light on these technologies at a time when we can certainly use the good news.
John Sabia is the CFO of Medical Infusion Technologies (MIT), developer of the ProVector—an innovative biopesticide device that is working to solve the infectious-disease problems in regions such as Haiti.
With a disaster as slow and torturous as the BP leak, even the incredible earthquake that literally brought Haiti’s capital to the ground just five months ago has suddenly lost its news luster. But that nation, already consistently running among the highest malaria rates in the world, remains under increased mosquito pressure—with the start of hurricane season threatening to make it even worse.
MIT currently has 1,600 ProVectors deployed in several locations throughout Haiti and along the Dominican Republic. Sabia can explain how the ProVector works and report on its success—not just in the Caribbean, but also in the more than 70 other active community projects in more than 30 countries throughout South Africa, Asia and Latin America.
Tonight's guest, John Sabia, is a retired police officer with 23 years law-enforcement experience, including 11 years as a supervisor and SWAT Team Leader with the City of Hialeah in Dade County, Florida. He moved to Savannah, Georgia, and entered into ministry work at The Sanctuary of Savannah for five years as director of their homeless mission, and an additional five years as the church administrator. In 2006, he began work at Medical Infusion Technologies and MIT Ambulatory Care Center as the companies’ controller. In 2007, John was named the CFO of MIT Holding, Inc., a publically traded company and parent company of the Infusion and the Ambulatory Care Center. He was then appointed Project Director for MIT’s acquired rights to a new product—ProVectorTM—a biopesticide designed to attract and kill mature mosquitoes. John’s educational background includes an associates’ degree in pre-law, a bachelor’s in criminal justice and a masters of science degree in public administration. John’s hobbies include music, playing drums, snow skiing and firearms shooting.
Join us tonight as we discuss this topic on the Political Pistachio Radio Revolution at 7:00 pm Pacific. Tune in at BlogTalkRadio.com/PoliticalPistachio.
No comments:
Post a Comment